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The composition of synovial fluid in rheumatoid arthritis (RA) is complex and strongly influences the microenvironment of joints
and it is an inseparable element of the disease. Currently, “in vitro” studies are performed on RA cells cultured in the presence
of either recombinant proinflammatory cytokines-conditioned medium or medium alone. In this study, we evaluated the use of
synovial fluid, derived from RA patients, as optimal culture condition to perform “in vitro” studies on RA synovial fibroblasts. We
observed that synovial fluid is more effective in inducing cell proliferation with respect to TNF-alpha or culture medium alone.
Spontaneous apoptosis in fibroblasts was also decreased in response to synovial fluid.The expression of proinflammatory cytokines
in the presence of synovial fluid was significantly elevated with respect to cells cultured with TNF-alpha or medium, and the overall
morphology of cells was also modified. In addition, modulation of intracellular calcium dynamics elicited in response to synovial
fluid or TNF-alpha exposure is different and suggests a role for the purinergic signalling in the modulation of the effects. These
results emphasize the importance of using RA synovial fluid in “in vitro” studies involving RA cells, in order to reproduce faithfully
the physiopathological environmental characteristic of RA joints.
1. Introduction
Rheumatoid arthritis (RA) is an inflammatory disease char-
acterized by infiltrating leukocytes, monocytes, and macro-
phages in the joint synovial fluid (SF) and in the surrounding
synovial tissue [1]. These cells play a critical role in the
pathogenesis of RA, by secreting proinflammatory cytokines,
which, in turn, perpetuate joint destruction [2, 3]. Fibroblast-
like synoviocytes (FLS), in the synovial intimal lining, also
contribute to inflammation of the joint and destruction of the
cartilage and bone, through cell-cell contact as well as elab-
oration of soluble products, such as cytokines, chemokines,
growth factors, prostaglandins, and leukotrienes [4]. SF thus
condenses a mix of factors, secreted by all the cells located
within the joint, with prosurvival and proliferative effects
that are important in the development of expanded fibroblast
network and in the maintaining the inflammatory response
[4, 5].
Synovial fluid from RA patients (RA SF) contains higher
levels of IL-1𝛽, IL-6, and TNF𝛼 than synovial fluid from
osteoarthritis (OA) patients [6–8]. The effects of these cyto-
kines include the induction of cytokine synthesis, the up-
regulation of adhesion molecules, the activation of osteo-
clasts, the induction of other inflammatorymediators such as
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prostaglandins, nitric oxide, and matrix metalloproteinases,
the induction of the acute phase response, and the activation
of B cells (IL-6).
The RA joint microenvironment also contains high levels
of IL-15, it stimulates migration of neutrophils and T lym-
phocytes into the joint [9, 10], it protects these cells from
apoptosis [11], and it induces triggering and proliferation of T
cells [12, 13]. In addition, IL15 indirectly induces the expres-
sion of proinflammatory cytokines TNF-𝛼, IL-1𝛽, IL-17, and
IL-8, as well as inflammation-inciting free radicals [14–18].
IL15 also participates in FLS activation [10] and in the local
bone destruction [19].
IL-17 is higher in RA SF, compared with the con-
centrations found in OA patients [20]. This cytokine has
pleiotropic effects on leukocytes and stromal cells, and it
induces IL-6 and IL-8 production by fibroblasts and stimu-
lates macrophage IL-1 and TNF-𝛼 production [21]. IL-17 is
thought to play a crucial role in the bone reabsorption process
during RA [21]. Other cytokines increased in RA SF are as
follows: IL-8 [22] involved in cellular recruitment, GM-CSF
involved in macrophage development, and IL-23 involved in
increasing Th17 lymphocytes differentiation [5]. In RA SF,
there are also soluble mediators of inflammation, such as
prostaglandins, leukotrienes, and matrix metalloproteinases,
which may diffuse from blood and/or be formed locally
within the joint cavity. Elevated IL-18 levels have been
detected in synovial tissues and synovial fluids of RApatients,
in significantly higher levels with respect to OA controls [23].
This inflammatory cytokine acts as an angiogenic mediator
and leukocyte chemoattractant [24].
RA synovial cells are characterized by a resistance to
apoptosis, and this contributes to the accumulation of cells
in the rheumatoid lesion. In the inflamed rheumatoid joint,
synovial fluid factors tend to inhibit the apoptosis of CD4+
T cells, neutrophils [25, 26], and FLS [4]. In addition, this
impaired apoptosis may contribute to the development of
the microenvironment and to maintain the inflammatory
response that characterizes established RA [4, 27]. SF factors
that contribute to cells survival are the high levels of common
𝛾-chain cytokines (IL-2, IL-4, and IL-15), G-CSF, GM-CSF,
and macrophage derived IFN-𝛼. Nitric oxide (NO) levels
are also increased in RA synovial fluid. NO mediates many
different cell functions at the site of synovial inflammation,
including cytokine production, signal transduction, mito-
chondrial functions, and apoptosis [28, 29].
Multiple mechanisms by which NO may regulate apop-
tosis have been identified [30], one of them might be the
suppression by NO donor of the proteolytic processing and
activation of caspase-3 in Fas-treated synovial cells [31]. Like
NO, thioredoxin 1 (Trx1) levels are elevated in the synovial
tissue, fluid, and serum of RA patients [32, 33]. Trx1 has
multiple biological activities in regulation of apoptosis, albeit
themechanisms responsible for these activities have not been
completely established [29].
The composition of SF is very complex and strongly
influences the microenvironment of joints, thus representing
an inseparable element of the disease. For these reasons
we think that “in vitro” studies about the RA pathology
should be performed in SF conditioned medium, rather
than recombinant cytokines conditionedmediumormedium
alone, in order to recreate the correct physiopathological
microenvironment, typical of RA. In our study we compared
the effect of SF, TNF𝛼, and the medium alone on “in vitro”
RA FLS, which play pivotal roles both in the initiation and
the perpetuation of RA. We observed a greater response of
the synovial fibroblasts to SF to confirm our hypothesis.
2. Material and Methods
2.1. Patients. Synovial membranes were obtained from 10
RA patients undergoing synovectomy or arthroplasty. SF was
obtained from 30 patients with established RA.The study was
approved by the Hospital Ethics Committee of the Gaetano
Pini Hospital of Milan (Italy). All patients signed informed
consent to take part in the study.
2.2. Isolation of Synovial Fibroblasts and Cell Cultures. Pri-
mary RA synovial fibroblasts were isolated from the syn-
ovial tissue of RA patients. The tissues were minced and
treated for 4 h with 2.5mg/mL of type I collagenase (Sigma
Aldrich, Saint Louis, MO, USA) in Dulbecco’s modified
Eagle’s medium (DMEM) (Euroclone, Italy) at 37∘C in 5%
CO
2
. Dissociated cells were then centrifuged at 1000×g,
resuspended in DMEM supplemented with 10% fetal calf
serum (FCS) (Fetalclone1 Hyclone Logan, UT, USA), 2mM
L-glutamine, 100 units/mL penicillin, and 100mg/mL strep-
tomycin (Euroclone, Italy), and plated in 75 cm2 flasks (Primo
Cell Culture Flask, Euroclone, Italy). After overnight culture,
nonadherent cells were removed, and adherent cells were
cultivated in DMEM supplemented with 10% FCS. The
cultures were kept at 37∘C in 5% CO
2
, and the medium
was replaced every 3 days. The purity of the cells was tested
by flow-cytometric analysis using phycoerythrin-conjugated
anti-CD14 (PharMingen, San Diego, CA, USA) and fluo-
rescein isothiocyanate phycoerythrin-conjugated anti-CD3,
anti-CD19, anti-CD14, or anti-Thy-1 (CD90) monoclonal
antibodies (R&D Systems Minneapolis, MN). A FACS Cal-
ibur flow cytometer (488Ex/620Em) (Becton Dickinson, San
Jose´, CA, USA) was used for the analysis. At passage 3,
the cells were morphologically homogeneous and exhibited
the appearance of FLS, with typical bipolar configuration
under inverse microscopy. Most cells (>98%) expressed the
surface markers for fibroblasts (Thy-1) and were negative for
the expression of CD3, CD19, and CD14. Synoviocytes from
passages 3–8 were used in each experiment.
SF was directly aspirated from the joints of RA patients,
and the fluid was collected into heparinized tubes and spun
at 1000×g for 10min. The acellular portion of SF was stored
at −80∘C before use.
2.3. Synovial Fibroblasts Proliferation Assays. FLS were cul-
tured in complete medium alone or in the presence of
recombinant human tumor necrosis factor-alpha (TNF𝛼)
(25 ng/mL) (Immunological Sciences, Italy) or SF, at the
dilution of 1 : 8 in culture medium. We used three pools of
SF, each from 10 RA patients’ fluid, in order to minimize
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the variability in responses among different pools. At indi-
cated time points the evaluation of newly synthesized DNA
was carried out using the Click-iT EdU HCS Assay (Life
Technologies Italia) in accordance with the kit instructions.
5-Ethynyl-2󸀠-deoxyuridine (EdU) (10𝜇M) was added to the
cultures 24 h before the detection, cells were then fixed and
permeabilized, and EdU incorporated into newly synthesized
DNA was detected using the fluorescent Alexa Fluor 488
azide. Analysis was performed using a confocal microscopy.
Data were obtained from triplicate experiments.
2.4. Detection of Apoptosis. The detection of apoptosis was
performed by the annexin V-fluorescein isothiocyanate (FITC)/
propidium iodide (PI) kit (BioLegend, San Diego, CA) accord-
ing to the manufacturer’s instructions. Briefly, after treat-
ments cells were washed and resuspended in annexin V bind-
ing buffer, and then annexin V-FITC and propidium iodide
(PI) solutionwere added.After 15min at room temperature in
the dark, annexin V binding buffer was added. The resulting
fluorescence was detected by flow cytometry (FACScan-
Becton Dickinson, Mountain View, CA) with CellQuest
analysis software. At least 2000 cells were analysed for each
sample. The percentage of apoptosis was calculated as apop-
totic index considering cells both in early and late apoptosis.
2.5. Real-Time RT-PCR. FLS were incubated in absence or
presence of TNF𝛼 (25 ng/mL) or SF (1 : 8 dilution in culture
medium). After 7 days cells were processed in triplicate with
the TaqMan Gene Expression Cells-to-CT Kit (Life Tech-
nologies Italia) according to the manufacturer’s instructions.
Briefly, cells were washed with cold PBS and resuspended in
Lysis Solution + DNAse I and incubated for 5min at room
temperature. Stop solution was then added and after 2min of
incubation at room temperature the samples were transferred
at −80∘C. TaqMan Gene ExpressionMaster Mix and TaqMan
Gene Expression Assays (Life Technologies Italia) were used
to perform real-time quantitative polymerase chain reaction.
mRNA expression of IL1𝛽, IL6, IL15, and TNF𝛼 was eval-
uated. Data were analysed according to the comparative Ct
method and were normalized by GAPDH expression in each
sample.
2.6. Actin Cytoskeleton. FLS were cultured on coverslips to
a 10% to 20% confluence and then incubated in absence or
presence of TNF𝛼 (25 ng/mL) or SF (1 : 8 dilution in culture
medium). After 7 days cells were fixed with 4% formaldehyde
for 15min at room temperature followed by permeabilization
of the cells with PBS plus 0.1% Triton X-100 for 5min. 5%
nonfat milk (30min) was used to prevent nonspecific bind-
ing. Cells were incubated with Alexa Fluor 594 Phalloidin
(actin filament staining; Invitrogen) for 15min. The stained
cells were washed with PBS and mounted on a glass slide.
A Zeiss Axiovert 200M fluorescent microscope was used for
visualization with the appropriate filters, with Zeiss Axio-
version 4.7 software (Jena, Germany).
2.7. Intracellular Calcium Measurements. Cultures were loaded
for 35–40min at 37∘Cwith 2𝜇MFura-2-AM in Krebs-Ringer
solution buffered with HEPES, 125mM NaCl, 5mM KCl,
1.2mM MgSO
4
, 2mM CaCl
2
, 10mM glucose, and 25mM
HEPES (pH 7.4) and were washed twice with prewarmed
Krebs-Ringer solution before recordings were made. The
recording setting comprised an inverted microscope (Leica,
DMI600B) equipped with a Ca2+ imaging unit. Polychrome
IV (TILL Photonics; Germany) was used as a light source.
Fura-2 fluorescence images were collected with a Andor
CCD Camera (Axon Instruments, CA, USA) and analyzed
with Imaging WorkBench 6 (INDEC BioSystem, Santa Clara
USA). Single-cell 340/380 nm fluorescence ratios were anal-
ysed with Origin 6.0 (Microcal Software Inc., MA, USA).
2.8. Statistical Analysis. Statistical analysis was performed
using Student’s 𝑡-test for matched pairs. Differences with a
confidence level of >95% were considered statistically signif-
icant (𝑃 < 0.05).
3. Results
To compare the effect of SF, TNF𝛼, and culture medium
alone, we first evaluated the proliferation of synovial fibrob-
lasts, established from rheumatoid synovial tissue. Cells
were cultured in medium additioned with 10% FCS in the
presence/absence of either TNF𝛼 or SF from RA patients.
We utilized TNF𝛼 at the optimal concentration of 25 ng/mL
as our reference standard, since this concentration is known
to induce maximal cell proliferation of synovial fibroblasts.
We used three SF pools; at a final dilution of 1 : 8 in culture
medium, the lower dilution is able to induce maximal cell
proliferation of synovial fibroblasts (data not shown).
Exposure to SF provided a significant growth advantage
for FLS, compared with exposure to TNF𝛼 or medium alone,
with an increase in DNA synthesis that was evident already
after 48 h of incubation, and it was also maintained at later
times (Figure 1). Comparing the three different pools, we did
not observed a significant difference in cellular responses.We
also evaluated the influence of SF on apoptosis, given that it is
known that RA FLS are more resistant to apoptosis, and one
of the possible mechanisms responsible for this resistance is
the presence of antiapoptotic factors in the SF. We assessed
the spontaneous apoptosis of FLS cultured in medium alone,
in medium with SF or with TNF𝛼. Our results indicate
that the presence of SF in the culture medium significantly
decreased apoptosis, compared to themedium alone, and this
protective effect on the cells increased when we extended the
treatment beyond 48 h (i.e., 7 days). Also in this condition,
no differences between the three SF pools were observed. In
the presence of TNF𝛼, a protective effect on apoptosis was
observed, but this effect was less than the one induced by SF
(Figure 2).
Then, we explored the modulation of the expression of
four inflammatory cytokines known to be involved in RA
pathology, namely, IL1𝛽, IL6, IL15, and TNF𝛼. FLS were
exposed to SF or TNF𝛼 and selected gene expression was
then quantified by real-time PCR. As shown in Figure 3,
unstimulated FLS constitutively produced IL1𝛽, IL6, IL15, and
TNF𝛼, as expected, and the chronic exposure to SF or TNF𝛼
increased the expression of these cytokines. The mRNA
expression was strongest in cells exposed to the three SF
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Figure 1: RA fibroblast-like synovial cells proliferation in the presence of synovial fluid or TNF𝛼. FLS were cultured in the presence of TNF𝛼
(25 ng/mL) or three SF pools (1 : 8 dilution in culture medium).TheDNA synthesis was evaluated after 24 h incubation with 10𝜇M5-ethynyl-
2󸀠-deoxyuridine (EdU). Cells were then fixed and permeabilized, and EdU incorporated into newly synthesized DNA was detected using
the fluorescent Alexa Fluor 488 azide. Analysis was performed using a confocal microscope. Data were obtained from triplicate experiments.
Results are shown as%of proliferation:%= (nuclei stainedwith Edu/total nuclei)× 100 and represent four independent experiments. Confocal
microscopy images of a representative experiment are shown: cells cultured for 48 h in alone medium (a), TNF𝛼 (b), or SF pools (c, d, e), cells
cultured for 72 h in medium alone (f), TNF𝛼 (g), or SF pools (h, i, j). Green staining: newly synthesized DNA, red staining: Hoechst staining
of total DNA. ∗𝑃 < 0.05 versus FLS; #𝑃 < 0.05 versus FLS + TNF𝛼.
pools, and its maximal stimulatory effect was detected after
7 days of exposure. Given that we did not evidence signif-
icant differences of the responses interpool, neither in cell
proliferation and apoptosis nor in the expression of cytokines,
we used a single SF pool for the subsequent experiments.
We concentrated our attention on the effect of SF and TNF𝛼
on cytoskeletal reorganization in RA FLS (Figure 4). Indeed,
it is known that these cells exhibit rearranged cytoskeleton
that may lead to morphological changes, ultimately result-
ing in the “transformed” phenotype of the cells, characterized
by increased migration, adhesion, and proliferation prop-
erties. We observed that “in vitro” treatments with SF and
TNF𝛼 induced the reorganization of the actin cytoskeleton,
but SF effects on cytoskeleton and morphological changes
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Figure 2: Effects of synovial fluid and TNF𝛼 on spontaneous apop-
tosis of RAfibroblast-like synovial cells. RA synovial fibroblasts were
cultured in the presence of TNF𝛼 (25 ng/mL), three SF pools (1 : 8
dilution in culturemedium), ormediumalone. Apoptosis was evalu-
ated at the indicated times. Cells were stained with annexin V-FITC
and propidium iodide and analysed by flow cytometry. Apoptotic
cells were measured as the percentage of annexin V-positive/PI-
positive cells. Results are expressed as the mean percentage ± SD
from four individual experiments. ∗𝑃 < 0.05 versus FLS; #𝑃 < 0.05
versus FLS + TNF𝛼.
were more pronounced, with an observable cell spreading
effect.
Subsequently, a functional characterization of FLS,
exposed to either TNF𝛼 or SF, was carried out by quantitative
evaluation of intracellular calcium dynamics. As a first step,
RA fibroblasts were exposed to TNF𝛼 or SF for either 2
or 7 days prior to experimental recording. A quantitative
evaluation of basal intracellular calcium levels did not show
particular changes in the resting status of FLS exposed to the
different conditions (Figure 5(a)). However, when the same
cells were exposed to inflammatory challenge (such as 1mM
ATP resembling exacerbated extracellular inflammatory
conditions, such as the ones which characterize RA patho-
logical contexts), significant differences were observed, both
in terms of percentage of responding cells as well as peak
intensity of response. In particular, already after 48 h of
exposure, FLS primed with TNF𝛼 showed a significantly
higher intensity of response with respect to SF (Figure 5(b)),
even though this was not coupled to a concomitant change in
percentage of responding cells (Figure 5(c)), thus suggesting
an acute effect of TNF𝛼 on the presence of P2 purinergic
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Figure 3: Effects of synovial fluid and TNF𝛼 on mRNA expres-
sion of proinflammatory cytokines in RA fibroblast-like synovial
cells. FLS were incubated in absence (FLS) or presence of TNF𝛼
(25 ng/mL) (FLS + TNF) or three different synovial fluid pools (FLS
+ SF) (1 : 8 dilution in culture medium). After 7 days cells were
analysed for IL1𝛽, IL6, IL15, and TNF𝛼mRNA expression by quanti-
tative RT-PCR. Data were analysed according to the comparative Ct
method andwere normalized byGAPDHexpression in each sample.
Relative mRNA levels were calculated based on the Ct values,
corrected for GAPDH expression, according to the equation: 2−ΔCt
[ΔCt = Ct(TNF𝛼, IL1𝛽, IL6, or IL15) − Ct(GAPDH)]. Data are
expressed as mean ± SD. ∗𝑃 < 0.05 versus FLS; ∗∗𝑃 < 0.05 versus
FLS + TNF𝛼.
receptors at the plasma membrane. At 7 days, the situation
was somewhat even more drastic but different, with a signif-
icantly higher increase both in the percentage of responsive
cells as well as in the mean peak amplitude of response in SF-
primed FLS, as compared with TNF𝛼 samples (Figures 5(b)
and 5(c)).
Overall, TNF𝛼 exposure seemed to have an acute effect
at shorter times of exposure on the quantity of functional P2
receptor at the plasma membrane of FLS, which is somewhat
maintained at longer times of exposure; on the contrary, SF-
exposed FLS showed an important change in responsiveness
at longer times of exposure. It is very interesting to observe
that after 7 days, all RA FLS exposed chronically to SF
responded to ATP exposure with a rapid kinetic, typical of
ionotropic channel activation. In order to confirm this hypo-
thesis, the experiment was replicated by administering 1mM
ATP in the absence of extracellular calcium. FLS functional
response was in this case completely abolished (Figure 6).
These data suggest that the ATP-mediated response of FLS is
due to the ionotropic component of the purinergic receptor
family (P2X), rather than the metabotropic component (P2Y
receptor).
6 Mediators of Inflammation
(a) (b)
(c)
Figure 4: Effect of synovial fluid and TNF𝛼 on cytoskeleton reorganization in fibroblast-like synovial cells. RA synovial fibroblasts were
cultured for 7 days in the presence of TNF𝛼 (25 ng/mL) (b), SF pool 1 (1 : 8 dilution in culture medium) (c), or medium alone (a). Actin cells
were stained with Alexa Fluor 594-Phalloidin.
4. Discussion
The composition of SF in RA pathology is very complex and
strongly influences the microenvironment of joints. In fact, it
is an inseparable element of the disease and for these reasons
we think that “in vitro” RA studies should be performed in
the presence of SF in the culture medium, to recreate the
physiopathological microenvironment of RA. In this study,
we compared the effect of TNF𝛼, a proinflammatory cytokine
typically used for “in vitro” RA studies, with respect to SF
and the culturemedium alone on RA fibroblast synovial cells,
to verify our hypothesis. Our observations were performed
using three different pools of SF, each from 10 RA patients’
fluid. We used the pools of RA synovial fluids to minimize
the variability in responses between the different individual
synovial fluid samples and to ensure the reproducibility of
the results. In addition, we decided to use pools composed
of 10 RA patients’ fluid to reduce the variability in responses
between the different pools. We used FLS because their
involvement and critical contribution to the initiation and
perpetuation of the disease are well known and are char-
acterized, along with their ability to modulate both joint
destruction and propagation of inflammation [4]. Chal-
lenged FLS show alterations in morphology and behaviour,
including apoptotic responses, inappropriate production
of chemokines, adhesion molecules, and matrix-degrading
components. For their active role in RA, FLS represent today
an important target for novel therapeutic approaches aimed
at inhibiting joint destruction. It is well known that the sig-
nificantly increased proliferation and insufficient apoptosis of
FLS are implicated in the pathogenesis and progression of RA
[34, 35]. Our observations indicate that the presence of SF in
the culture medium can strongly influence these aspects of
FLS, in amore efficientway than that observed in the presence
of TNF𝛼 and culturemedium alone (Figures 1 and 2). Indeed,
all the three SF pools provided a significant growth advantage
for FLS, their effect on DNA synthesis was more evident,
compared with TNF𝛼 or medium alone, and it was also
maintained for longer time in culture (data not shown).
Along the same line, the spontaneous apoptosis of FLS
observed was decreased in the presence of the SF pools. This
effect was detected starting from 48 h following treatment,
with a more pronounced effect at 72 h, and the persistence
of SF for longer times in the culture medium stabilized
apoptosis. After 7 days, an increase in spontaneous apoptosis
in cells cultured with medium alone was detected, probably
due to nutrient limitations in the culture supernatant and/or
the accumulation of metabolites, while the cells cultured in
the presence of SF maintained a very low level of apoptosis,
significantly lower than TNF𝛼-cultured cells. Here we did not
want to analyse the mechanisms which promote resistance
to apoptosis in SF-maintained synovial cells, given that this
aspect is documented and many factors contribute to this
mechanism [27–29, 31], but our observations highlight the
important role of SF in conferring this resistance to RA FLS
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Figure 5: Effect of TNF𝛼 and synovial fluid on intracellular calcium dynamics in ATP-challenged fibroblast-like synovial cells. (a)
Quantitative evaluation of basal intracellular calcium levels in FLS exposed to either TNF𝛼 or SF pool 1 for either 2 or 7 days. No significant
changes in basal intracellular calcium dynamics in the different experimental conditions are observed. A drastic change in amplitude of
response (b) and percentage of responding cells (c) to 1mM ATP is observed between TNF𝛼 and SF samples. In particular, TNF𝛼 seems to
have an acute effect at shorter times of exposure on the quantity of functional P2 receptor at the plasma membrane, while SF samples show
an important change in responsiveness at longer times of exposure.
“in vitro.” For this reason, we think that SF should be used
as a more physiologically relevant tool in “in vitro” studies,
in particular when new therapeutic molecules involved in
apoptotic pathways are evaluated.
When we compared the effects of SF and TNF𝛼 on
the expression of cytokines known to be involved in RA
pathology, such as IL1𝛽, IL6, IL15, and TNF𝛼, we observed
that chronic exposure to SF (7 days) induced more pro-
nounced effects on the cytokines synthesis in synovial
fibroblasts (Figure 3). This supports our hypothesis that
the presence of SF would ensure “in vitro” FLS culture
conditions more similar to the real environmental charac-
teristics of the RA joints. SF influences the expression of
genes involved in modulation of synovial cells and these cells
have specific characteristics due to their high inflammation
state. In respect to the three different SF pools, we did
not evidence significant differences of the responses inter-
pool, neither in cell proliferation and apoptosis nor in the
expression of cytokines (Figures 1, 2, and 3), to confirm
that the elevated number of synovial fluid samples, 10, used
in each pool reduces the variability in responses between
the different pools. This is of particular importance when
considering the possibility of using such a pool for drug
profiling purposes.
Cytoskeleton plays a critical role in the regulation of
various cellular processes linked to cell transforming and
tumorigenesis, such as contact inhibition and anchorage-
independent cell growth [36]. RA FLS exhibit rearranged
cytoskeleton, and this reorganization may lead to morpho-
logical changes in the FLS, ultimately resulting in the “trans-
formed” phenotype of these cells, characterized by increased
migration, adhesion, and proliferation properties [37].
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Figure 6: P2X but not P2Y-dependent response of fibroblast-
like synovial cells exposed to synovial fluid. Representative graph
showing kinetics of response of FLS exposed to SF pool 1 for 7 days.
It is very interesting to observe that after 7 days, all RA FLS exposed
chronically to SF respond to ATP exposure. When the experiment
is replicated in the absence of extracellular calcium, the functional
response is completely abolished. This suggests that the ATP medi-
ated response of FLS is due to P2X and not P2Y receptor.
Previously reports found that recombinant TNF𝛼
induced morphological changes [38] as well as the reorgan-
ization of the actin cytoskeleton. In addition, it was dem-
onstrated that pharmacological inhibition of actin cytoskel-
eton dynamics alters potential pathogenic properties of the
synovial fibroblast, such as proliferation, migration, and
resistance to apoptosis. Here we compared the effect of
TNF𝛼 and SF on cytoskeleton reorganization (Figure 4) and
observed that although both “in vitro” treatments induced
the reorganization of the actin cytoskeleton, FLS cultured
with SF exhibited more pronounced stress fibres and more
significant effects on cytoskeletal and overall morphological
changes.
When we focused our attention on the functional
responses of FLS subjected to the different experimental sce-
narios, in terms of quantitative evaluation of intracellular
calcium dynamics, we confirmed a clear distinct effect of
TNF𝛼 and SF on FLS responsiveness. In particular, TNF𝛼
exerts a very rapid effect, with an increase in the peak of the
intensity response to 1mMATP exposure.This effect is main-
tained at longer times. In contrast, FLS exposed to SF show a
significant change at longer times of stimulation (i.e., 7 days)
with a striking increase in the percentage of responding cells
as well as in the mean peak amplitude of response, thus
suggesting a more chronic effect on the purinergic receptor
portfolio at the plasma membrane surface of challenged FLS.
We tried to give hints on the purinergic receptor components
influencing such differences and observed that FLS response
was completely abolished when cells were challenged with
ATP in the absence of extracellular calcium, thus suggesting
a role for the P2X rather than the P2Y component of the
purinergic receptor family in the observed effects.
A complete characterization of the purinergic receptor
components on the surface of FLS, challenged with either
TNF𝛼 or SF, would be worthy of future investigation in order
to give insights on the molecular reasons behind this clearly
observed effect.
5. Conclusion
These results emphasize the importance of using the RA SF
in “in vitro” studies of RA synovial fibroblasts rather than
typically used TNF𝛼 challenge, in order to ensure culture
conditions as similar as possible to those typical of the phys-
iopathological environmental in rheumatoid arthritis joints.
This should ensure the possibility to have more accurate
biological information, both to clarify the pathogenesis of
rheumatoid arthritis and to evaluate the therapeutic effective-
ness of new molecules.
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